11-(1-methyl-piperidin-4-ylidene)-6,11-dihydro-dibenzo[b,e]oxepine-3-carboxylic acid | 1017795-95-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: 11-(1-methyl-piperidin-4-ylidene)-6,11-dihydro-dibenzo[b,e]oxepine-3-carboxylic acid
• 英文别名: 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydrodibenz[b,e]oxepin-3-carboxylic acid；11-(1-methylpiperidin-4-ylidene)-6H-benzo[c][1]benzoxepine-3-carboxylic acid
• CAS: 1017795-95-7
• 化学式: C₂₁H₂₁NO₃
• 分子量: 335.403
• InChiKey: ZLWPRCZGGPLKPF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  25
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  11-(1-methyl-piperidin-4-ylidene)-6,11-dihydro-dibenzo[b,e]oxepine-3-carboxylic acid 、 二乙胺 生成 11-(1-methyl-piperidin-4-ylidene)-6,11-dihydro-dibenzo[b,e]oxepine-3-carboxylic acid ethylamide
  参考文献：
  名称：

  Tricyclic δ-opioid modulators

  摘要：

  本发明涉及三环δ-阿片受体调节剂。更具体地说，本发明涉及三环δ-阿片调节剂。还描述了使用本发明化合物的制药和兽医组合物以及治疗轻度到严重疼痛和各种疾病的方法。

  公开号：

  US08350041B2

文献信息

• Tricyclic delta-opioid modulators
  申请人：Carson R. John

  公开号：US20050009860A1

  公开（公告）日：2005-01-13

  The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

  该发明涉及三环δ-阿片受体调节剂。更具体地，该发明涉及三环δ-阿片调节剂。还描述了使用该发明化合物的制药和兽医组合物以及治疗轻度至严重疼痛和各种疾病的方法。
• Oxepin derivative
  申请人：Higashiura Kunihiko

  公开号：US20100004456A1

  公开（公告）日：2010-01-07

  The present invention provides a compound, an oxepin derivative having excellent histamine receptor antagonistic action, which is useful as an antihistamine. The oxepin derivative of the present invention has a potent histamine receptor antagonistic action. Further, the compound of the present invention shows low intracerebral migration even when a mouse that is orally administered with the compound is subjected to an intracerebral receptor binding test, so that the compound has preferred properties of alleviating side effects in the central nervous system, such as drowsiness. The oxepin derivative of the present invention is very useful as a novel antihistamine having smaller side effects in the central nervous system, such as drowsiness.

  本发明提供了一种化合物，即一种具有出色的组胺受体拮抗作用的噁吖啶衍生物，可用作抗组胺药。本发明的噁吖啶衍生物具有强效的组胺受体拮抗作用。此外，本发明的化合物即使经口给小鼠并进行颅内受体结合试验时，也表现出低颅内迁移，因此该化合物具有减轻中枢神经系统副作用（如嗜睡）的优良特性。本发明的噁吖啶衍生物非常有用，可作为一种新型抗组胺药，其中枢神经系统的副作用（如嗜睡）更小。
• TRICYCLIC DELTA-OPIOID MODULATORS
  申请人：Carson John R.

  公开号：US20090298867A1

  公开（公告）日：2009-12-03

  The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

  该发明涉及三环δ-阿片受体调节剂。更具体地，该发明涉及三环δ-阿片调节剂。还描述了使用该发明化合物的制药和兽医组合物以及治疗轻度至严重疼痛和各种疾病的方法。
• Thiozanthene derivatives as delta-opioid modulators
  申请人：Janseen Pharmacautica NV

  公开号：US07982042B2

  公开（公告）日：2011-07-19

  The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.

  本发明涉及三环δ-阿片受体调节剂。更具体地，本发明涉及三环δ-阿片调节剂。本发明还描述了利用本发明化合物治疗轻度至严重疼痛和各种疾病的药物和兽医组合物和方法。
• Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators
  申请人：Janssen Pharmaceutica N.V.

  公开号：US07589103B2

  公开（公告）日：2009-09-15

  Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows: wherein A, Z, Y, R1-R5 are defined herein.

  本发明涉及化合物、组合物及其治疗各种疾病和病症的方法，包括疼痛。这些化合物由以下公式I表示：其中A、Z、Y、R1-R5在此定义。